About Us
Verve Therapeutics was created with a singular focus: to protect the world from cardiovascular disease
Our Mission
We are striving to build the preeminent company developing gene editing medicines to treat patients with cardiovascular disease, leveraging the expertise and capabilities of our team whose singular focus is on addressing the root causes of the world’s most common cause of death. Our goal is to disrupt today’s chronic care model for treating cardiovascular disease by providing a new therapeutic approach with single-course gene editing treatments.
Verve brings together multiple breakthroughs in 21st century biomedicine — human genetic analysis, gene editing, messenger RNA (mRNA) -based therapies and lipid nanoparticle (LNP) delivery — to realize a new future of longevity and vitality for tens of millions of people around the globe with or at risk for cardiovascular disease.
Verve Team
Verve has been purpose-built for the task ahead, with a team of world-leading experts in cardiovascular medicine, human genetics, gene editing, delivery technologies, drug development and commercialization.
Our Team
Felix Acheampong, Ph.D.
Senior Scientist, Bioanalytical Mass Spectrometry
Michael Amaonye
Senior Research Associate, Editing and Discovery
Aaron Beach
Associate Director, Analytical Chemistry
Lisa Billings
Associate Scientist
Souvik Biswas, Ph.D.
Principal Scientist, Formulation & Chemistry
Maurine Braun
Senior Manager, Preclinical Operations and Toxicology
Paul Casaz, Ph.D.
Director, Formulation and Characterization
Alexandra Chadwick, Ph.D.
Associate Director, Preclinical Research and Development
Holly Chan
Manager, Project Management, Chemistry, Manufacturing and Controls
Huei-Mei Chen, Ph.D.
Senior Scientist, Gene Editing
Christopher J. Cheng, Ph.D.
Executive Director, RNA Technology & Manufacturing
Victoria Clendaniel
Senior Research Associate
Angela Cook
Chief of Staff
Kristopher Davis
Facilities and Lab Assistant
Ishwin Dembla, M.S.
Senior Scientist, Analytical Chemistry
Jamie DeNizio, Ph.D.
Senior Scientist
Joseph DePeter
Senior Process Development Engineer, mRNA Process Development and Tech Transfer
Andrew Dorsey
Research Associate, Formulation
Chaitali Dutta, Ph.D.
Principal Scientist, Pharmacology and Toxicology
Robin Eisner
Administrative and Operations Manager
Yasser (Yas) El-Gamal
Vice President, Legal Affairs and Chief Intellectual Property Counsel
Richard Falzone
Vice President, Clinical Operations
Nicole Franaszek
Research Associate, Formulation
Nancy Fuselli, BSc, RAC
Director, Quality Affairs
Jack Ganey
Associate Scientist
Soumya Gangopadhyay, Ph.D.
Senior Scientist, Bioassays and Editing
Sara Garcia, Ph.D.
Associate Principal Scientist, Computational Biology
Ryan Garrity
Senior In Vivo/In Vitro Research Associate
Kevin Gichuru
Senior Manager, Accounting
Zachary Glass, Ph.D.
Scientist, Formulation
Matthew Greenfield
Associate Director, Laboratory Operations
Hiep (Chris) Ho Huynh
Senior Accountant
Sowmya Iyer, Ph.D.
Associate Principal Scientist, Computational Biology
Paris James
Research Associate, RNA Technology
Hari Jayaram, Ph.D.
Vice President, Editing and Discovery
Lisa Kasiewicz, Ph.D.
Senior Scientist, Formulations
Jaime Kirk
Senior Manager, Technical Accounting
Danielle Klausman
Senior Manager, Regulatory CMC
Sunita Kumar
Associate Director, Quality Assurance
Jeong-Ah Kwon
Scientist, RNA Analytics
Nick Laschkewitsch
Research Associate, mRNA Process Development
Jennifer Lavoie
Associate Director, CMC Program Management
Jeff Li
Associate Scientist
Jimmy Li
Staff Accountant
James Madsen, Ph.D.
Associate Director, Mass Spectrometry
Padma Malyala
Executive Director, Formulation and Characterization
Jessica Mangano
Senior Engineer, RNA Technology and Manufacturing
Yuri Matsumoto, Ph.D.
Principal Scientist, Bioanalytical and Translational Sciences
Anne Marie Mazzola
Study Coordinator and Scientist, Pharmacology and Toxicology
Harlisa Minaya
Senior Human Resources Generalist
Ralitsa Mintcheva
Controller
Taiji Mizoguchi, Ph.D.
Senior Scientist, In Vivo Biology
Ash Nagpal
Senior Process Engineer
Robyn Naigles
Administrative and Operations Associate
Yusuf Nasrullah
Scientist
April O'Neil
Associate Director, Human Resources
Alline Pacheco, Ph.D.
Senior Scientist, Gene Editing
Colin Platt, Ph.D.
Scientist, In Vivo Pharmacology
Brent V. Powell, Ph.D.
Scientist
Kallanthottathil G. Rajeev, Ph.D.
Vice President, CMC
Caroline Reiss, Ph.D.
Senior Scientist, RNA Technology and Manufacturing
Huilan Ren
Associate Scientist
Ellen Rohde, Ph.D.
Vice President, Pharmacology and Toxicology
Leocadia Ruiz
Director, External Quality Control
Athul Sanjeev
Research Associate
Derek Sethachutkul
Senior Director, External Manufacturing Technical Operations
Wynn Shatzer
Research Associate
Jax Shay
Senior Research Associate, Formulation & Characterization
Andrew Sheely
Executive Director, Information Technology
Mary Stahley, Ph.D.
Associate Director, Process Development
Mila Stanojevic
Research Associate, RNA Analytics
Casey Stevens, Ph.D.
Scientist, RNA Process Development
Ryan Stoeckel
Associate Director, Procurement
Leslie Stolz, Ph.D.
Vice President, Regulatory Affairs
Lynnsey Street
Associate Scientist
Scott Vafai, M.D.
Executive Director, Translational Medicine
Kui Wang, Ph.D.
Associate Principal Scientist, RNA and Process Development
Francis Wong
Associate Scientist
Leadership
Andrew Ashe, J.D.
President and Chief Operating Officer
Maggie Beaudoin
Vice President, Finance
Andrew Bellinger, M.D., Ph.D.
Chief Scientific Officer
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Joan Nickerson
Senior Vice President, Human Resources and Facilities
Jason Politi
Senior Vice President, Technical Operations
Founders
Burt Adelman, M.D.
Co-Founder and Chairman of the Board
J. Keith Joung, M.D., Ph.D.
Co-Founder
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Kiran Musunuru, M.D., Ph.D., MPH
Co-Founder and Senior Scientific Advisor
Anthony Philippakis, M.D., Ph.D.
Co-Founder and Scientific Advisory Board Member
Issi Rozen, MBA
Co-Founder and Strategic Advisor
Barry Ticho, M.D., Ph.D.
Co-Founder
Scientific Advisory Board
Eugene Braunwald, M.D.
Scientific Advisory Board Member
Andrew Geall, Ph.D.
Scientific Advisory Board Member
Penny M. Heaton, M.D.
Scientific Advisory Board Member
Kiran Musunuru, M.D., Ph.D., MPH
Co-Founder and Senior Scientific Advisor
Anthony Philippakis, M.D., Ph.D.
Co-Founder and Scientific Advisory Board Member
Daniel J. Rader, M.D.
Scientific Advisory Board Member
Collaborations and Licensing
Verve has assembled a portfolio of gene editing and delivery technologies through strategic collaborations and licensing agreements with industry leaders, including Beam Therapeutics, the Broad Institute, Harvard University and Acuitas Therapeutics, Inc.